Keynote-U01: A Phase 2 Umbrella Study Of Investigational Agents Plus Pembrolizumab-Based Therapy For Advanced Nsclc
JOURNAL OF THORACIC ONCOLOGY(2021)
Key words
nonesmall-cell lung cancer, pembrolizumab, investigational agent
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined